Katie Rosen Kitchens
Co-founder of FabFitFun, Katie Rosen Kitchens has led its evolution as a female-focused media brand, from writing about great lifestyle products to getting them into people’s hands. Since launching the FabFitFun lifestyle box 2013, Rosen Kitchens has shifted her energy toward curating fresh and exciting brands for FabFitFun members and overseeing all brand partnerships and product development.
Building on this to place the brand at the intersection of content, community and commerce, Rosen Kitchens has spearheaded FabFitFun’s evolution into one of most-loved membership services that spans beauty, fashion fitness, home, tech and more. As editor in chief, Rosen Kitchens continues to oversee all of FabFitFun’s content including it’s quarterly lifestyle magazine, video, online and social posts, and spearheads FabFitFun’s charity initiatives.
After earning English and Sociology degrees from George Washington University, Rosen Kitchens joined the fashion, beauty, and nightlife guide Scheckys.com as its L.A. editor. She has written for an eclectic variety of magazines, newspapers and websites including the Los Angeles Times, Art and Living, Women’s Life, Dining Out, Pasadena Mag, LA Splash, and Venice News. In-between blogs and articles, Rosen Kitchens has worked in TV production on several shows including It’s Always Sunny in Philadelphia and Jackass, and has also had a few of her own plays produced.
On any given day Rosen Kitchens is testing out protein bars, experimenting with exfoliators, swinging kettlebells, seeking out sex secrets, hailing high/low styles, interviewing fit-lebrities, examining fast & slow food, investigating mood boosters, working out at work, cycling, and more, all to find the best in beauty, fashion, fitness, nutrition and wellness for her FabFitFun subscribers.
When Rosen Kitchens is not at FabFitFun, she can be found hiking, experimenting in the kitchen, and spending time with her husband Daniel and their daughters, Summer and Sienna.
Dr Jason Brown
Jason co-founded Ubiquigent in 2009 in collaboration with the University of Dundee, the Medical Research Council and a US biotech. Ubiquigent’s mission is to support and enable client ubiquitin system targeted drug discovery through the identification and characterisation of novel compounds across multiple therapeutic areas. The company is a provider of such collaborations and services worldwide to both commercial pharmaceutical and biotechnology companies as well as academic groups. Before starting Ubiquigent he was part of a biotech investment and operations group and involved in supporting molecular diagnostics, kinase drug discovery and various other drug discovery-focused service companies, along with evaluating investment opportunities. Prior to this he built and ran a kinase-focused assay development and drug discovery service facility for Upstate Biotechnology, a leading provider of cell signalling research products and services. Jason received his MPhil and DPhil from the University of Cambridge in association with Parke-Davis/Warner-Lambert (Pfizer), during which he identified a voltage-dependent calcium channel subunit as the novel molecular target of the blockbuster epilepsy and neuropathic pain drugs Neurontin and Lyrica. After his DPhil Jason worked in and subsequently ran an assay development group for Parke-Davis.